Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.91) per share. This is a 152.78 percent decrease over losses of $(0.36) per share from the same period last year.
Barclays Maintains Equal-Weight on Southern Copper, Lowers Price Target to $51
Barclays analyst Matthew Murphy maintains Southern Copper (NYSE:SCCO) with a Equal-Weight and lowers the price target from $61 to $51.
